Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study

被引：0
|
作者：
Naber, D. [1 ]
Hansen, K. [2 ]
Forray, C. [3 ]
Baker, R. A. [4 ]
Sapin, C. [5 ]
Beillat, M. [2 ]
Peters-Strickland, T. [6 ]
Nylander, A. G. [7 ]
Hertel, P. [8 ]
Andersen, H. Steen [9 ]
Eramo, A. [10 ]
Loze, J. Y. [11 ]
Potkin, S. [12 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany
[2] Lundbeck SAS, Global Hlth Econ & Epidemiol, Issy Les Moulineaux, France
[3] Lundbeck Res, Subst Abuse Behav Disorders, Paramus, NJ USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA
[5] Lundbeck SAS, Global Analyt, Issy Les Moulineaux, France
[6] Otsuka Pharmaceut Dev & Commercializat Inc, Global Clin Dev, Princeton, NJ USA
[7] H Lundbeck & Co AS, Corp Med Affairs, Valby, Denmark
[8] H Lundbeck & Co AS, Mood & Anxiety Disorders, Valby, Denmark
[9] H Lundbeck & Co AS, Biometr, Valby, Denmark
[10] Lundbeck LLC, Med Affairs & Phase Clin Affairs 4, Deerfield, IL USA
[11] Otsuka Pharmaceut Europe, Med Affairs, Uxbridge, Middx, England
[12] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA
来源：
EUROPEAN PSYCHIATRY | 2015年 / 30卷
关键词：
D O I：
10.1016/S0924-9338(15)30721-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
0923
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison
    K. Kumagai
    K. Harigane
    Y. Kusayama
    T. Tezuka
    H. Choe
    Y. Inaba
    T. Saito
    Osteoporosis International, 2018, 29 : 1637 - 1642
  • [22] Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison
    Kumagai, K.
    Harigane, K.
    Kusayama, Y.
    Tezuka, T.
    Choe, H.
    Inaba, Y.
    Saito, T.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (07) : 1637 - 1642
  • [23] Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study
    Miller, Paul D.
    Epstein, Sol
    Sedarati, Farhad
    Reginster, Jean-Yves
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 207 - 213
  • [24] Effects of aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by disease severity: a post-hoc analysis of QUALIFY
    Salzman, P.
    Schmidt, S. Nitschky
    Eramo, A.
    Hansen, K.
    Ettrup, A.
    Such, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S555 - S556
  • [25] Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study
    Potkin, Steven G.
    Loze, Jean-Yves
    Forray, Carlos
    Baker, Ross A.
    Sapin, Christophe
    Peters-Strickland, Timothy
    Beillat, Maud
    Nylander, Anna-Greta
    Hertel, Peter
    Schmidt, Simon Nitschky
    Ettrup, Anders
    Eramo, Anna
    Hansen, Karina
    Naber, Dieter
    PLOS ONE, 2017, 12 (08):
  • [26] Persistence With and Adherence to Paliperidone Palmitate Once-Monthly Injection for Schizophrenia Treatment in China and Japan
    Wang, Huaning
    Zhang, Yongjing
    Liu, Jin
    Chi, Rui
    Wu, Tao
    Zhang, Ting
    Zhang, Lili
    Jiang, Kun
    Qiu, Hong
    Dong, Wentian
    Si, Tianmei
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (01)
  • [27] ONCE-MONTHLY PALIPERIDONE PALMITATE COMPARED WITH ORAL ATYPICAL ANTIPSYCHOTIC TREATMENT IN PATIENTS WITH SCHIZOPHRENIA
    Kim, E.
    Starr, H. L.
    Bossie, C.
    Mao, Lian
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S318 - S318
  • [28] Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions
    Georgios Schoretsanitis
    Ekkehard Haen
    Daria Piacentino
    Andreas Conca
    Katharina Endres
    Fabio Carpi
    Christoph Hiemke
    Gerhard Gründer
    Michael Paulzen
    Clinical Pharmacokinetics, 2021, 60 : 1583 - 1589
  • [29] Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions
    Schoretsanitis, Georgios
    Haen, Ekkehard
    Piacentino, Daria
    Conca, Andreas
    Endres, Katharina
    Carpi, Fabio
    Hiemke, Christoph
    Gruender, Gerhard
    Paulzen, Michael
    CLINICAL PHARMACOKINETICS, 2021, 60 (12) : 1583 - 1589
  • [30] Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database
    Schoretsanitis, Georgios
    Haen, Ekkehard
    Piacentino, Daria
    Conca, Andreas
    Endres, Katharina
    Hiemke, Christoph
    Grunder, Gerhard
    Paulzen, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (08) : 1437 - 1443
12345